SlideShare a Scribd company logo
1 of 381
OER / RBE / LET
Dr ANJALIKRISHNA NP
PG RESIDENT
RADIOTHERAPY
OXYGEN ENHANCEMENT RATIO
OXYGEN EFFECT
• Cells are much more sensitive to radiation in the presence of oxygen
• The formation of RO2·, an organic peroxide, represents a non
restorable form of the target material; that is, the reaction results in a
change in the chemical composition of the material exposed to the
radiation.
• This reaction cannot take place in the absence of oxygen.
• Oxygen fixes ( ie , makes permanent ) the damage produced by free
radicals .
• In the absence of oxygen , damage produced by the indirect action
may be repaired .
The oxygen fixation hypothesis.
About two-thirds of the damage produced by x-rays is by indirect action mediated by free radicals. The
damage produced by free radicals in DNA can be repaired under hypoxia but may be “fixed” (made
permanent and irreparable) if molecular oxygen is available .
• To produce its effect , molecular oxygen must be present during the
radiation exposure or at least during the lifetime of the free radicals
generated by the radiation .
• Ie , Oxygen effect is time dependent .
1. O2 needs to be present during radiation . or
2. O2 has to be present within milliseconds after radiation .
• Radiation - ion pairs - free radicals
0.01 msec.
OXYGEN IS NATURAL RADIOSENITIZER .
• If molecular oxygen is present, DNA reacts with the free radicals (R·).
The DNA radical can be chemically restored to its reduced form
through reaction with a sulfhydryl (SH) group.
• SULFHYDRIL group is a natural radio protector which exert their
effect by scavenging free radicals .
• Oxygen and sulfhydryl only acts on indirect action and they do not
have any effect on direct action of radiation to DNA .
RADIOSENSITIVITY & O2 CONCENTRATION
• Very little change upto 20 mmHg.
• Sharp fall in sensitivity and reduces to half at around 3
mmHg.
• Maximum radio resistance at 1/100 mm of Hg .
• Oxygen tension in most of tissue is similar at venous
blood O2 tension ,ie 20-40 mmHg .So , MOST OF THE
NORMAL TISSUES HAVE GOOD SENSITIVITY TO
RADIATION.
EFFECT OF O2 on cell survival curve .
• So , to get the same surviving fraction , dose of RT to be increased
with decreasing oxygen tension .
• The ratio of RT to get the same SF in hypoxic cells to oxic cells is
known as OXYGEN ENHANCEMENT RATIO (OER).
• OER = DH / DO = D hypoxic/D aerobic
• Ratio of doses administered under hypoxic to aerated condition
needed to achieve the same biological effect is called oxygen
enhancement ratio .
• For sparsely ionizing radiations, such as x- and γ-rays, the OER at
high doses has a value of between 2.5 and 3.5.
• For a densely ionizing radiation, such as low-energy α-particles, the
survival curve does not have an initial shoulder; which means that all
hits results into cell kill and no sub lethal damage to be fixed by
oxygen .we can say , α-particle radiation is as effective for hypoxic
cells as for oxic cell .
• Intermediate value for fast neutrons , the OER for neutrons is about
1.6. For radiations of intermediate ionizing density, such as neutrons,
the survival curves have a much reduced shoulder
Survival curves for mammalian cells exposed to x-rays in the
presence and absence of oxygen are illustrated here;
• High dose region ; predominant process of cell kill is by accumulation
of sublethal damage ( cell killing by multiple hit event –MHE ) which
can be repaired ,so oxygen fix it and repair slows down .
• Low dose region ; cell killing is predominantly by single hit event –SHE
,no sublethal damage to be fixed up by oxygen ; so , in low dose
region OER = 2 ( x ray or gamma ray )
• Cells are much more sensitive to x-rays in the presence of molecular
oxygen than in its absence (i.e., under hypoxia).
• The ratio of doses under hypoxic to aerated conditions necessary to
produce the same level of cell killing is called the oxygen
enhancement ratio (OER).
• It has a value close to 3.5 at high doses (A)
• But may have a lower value of about 2.5 at x-ray doses less than
about 2 to 3 Gy (B).
• OER varies slightly during cell cycle .
• Cells in G1 phase have a lower OER than those in S, and because G1
cells are more radiosensitive, they dominate the low-dose region of
the survival curve.
• S PHASE > G1 PHASE > G2/M PHASE .
• OER OF S PHASE = 2.8 - 2.9
• OER OF G2/M PHASE = 2.3 -2.4
CLINICAL IMPORTANCE
• Various experimental solid tumors in animals have shown to have
hypoxic contents between 10 to 40 %, which limits the radio curability
• However , it should be remembered that even a minute proportion of
hypoxic cells will limit the radiocurability if treated with large single
fraction .
• There are abundant evidences to support the existence of hypoxic
cells in human tumour .
TUMOR HYPOXIA & DFS IN CA CERVIX
HYPOXIA & local tumor control in HEAD &
NECK CANCER
LINEAR ENERGY TRANSFER
• Linear energy transfer (LET) is the energy transferred per unit length
of the track.
• The special unit usually used for this quantity is kiloelectron volt per
micrometer (keV/μm) of unit density material.
• The LET (L) of charged particles in medium is the quotient of dE/dl.
• dE is the average energy locally imparted to the medium by a
charged particle of specified energy in traversing a distance of dl.
• L=dE/dl
Typical Linear Energy Transfer Values
• Linear energy transfer (LET) is the average energy deposited per unit
length of track.
• The track average is calculated by dividing the track into equal lengths
and averaging the energy deposited in each length.
• The energy average is calculated by dividing the track into equal
energy intervals and averaging the lengths of the track that contain
this amount of energy.
• The method of averaging makes little difference for x-rays or for
monoenergetic charged particles, but the track average and energy
average are different for neutrons.
• In the case of either x-rays or monoenergetic charged particles, the
two methods of averaging yield similar results.
• In the case of 14-MeV neutrons, by contrast, the track average LET is
about 12 keV/μm and the energy average LET is about 100 keV/μm.
• The biologic properties of neutrons tend to correlate best with the
energy average.
RELATIVE BIOLOGIC EFFECTIVENESS (RBE)
• The amount or quantity of radiation is expressed in terms of the
absorbed dose, a physical quantity with the unit of gray (Gy).
• Absorbed dose is a measure of the energy absorbed per unit mass of
tissue.
• Equal doses of different types of radiation do not produce equal
biologic effects.
• For example, 1 Gy of neutrons produces a greater biologic effect than
1 Gy of x-rays.
• The key to the difference lies in the pattern of energy deposition at
the microscopic level.
OPTIMAL LET
• why radiation with an LET of about 100 keV/μm is optimal in terms
of producing a biologic effect?
• LET of about 100 keV/μm is optimal in terms of producing a biologic
effect .
• At this density of ionization , the average separation in ionizing events
is equal to the diameter of DNA double helix (i.e., about 20 Å or 2 nm)
which causes significant DOUBLE STRAND BREAK .
• DSB are the basis of most biological effects .
• The probability of causing DSBs is low in sparsely ionizing radiation .
• The LET at which the RBE reaches a peak is much the same (about
100 keV/ μm) for a wide range of mammalian cells, from mouse to
human, and is the same for mutation as an end point as for cell
killing.
• Variation of relative biologic effectiveness (RBE) with linear energy transfer (LET) for survival of
mammalian cells of human origin.
The RBE rises to a maximum at an LET of about 100 keV/μm and subsequently falls for higher values
of LET.
Curves 1, 2, and 3 refer to cell survival levels of 0.8, 0.1, and 0.01, respectively, illustrating that the
absolute value of the RBE is not unique but depends on the level of biologic damage and,
therefore, on the dose level.
• In the case of x-rays, which are more sparsely ionizing, the probability
of a single track causing a DSB is low, and in general, more than one
track is required. As a consequence, x-rays have a low biologic
effectiveness.
• At the other extreme, much more densely ionizing radiations (e.g.,
with an LET of 200 keV/μm) readily produce DSBs.
• But energy is “wasted”
• Because, the ionizing events are too close together. RBE is the ratio
of doses producing equal biologic effect, this more densely ionizing
radiation has a lower RBE than the optimal LET radiation. The more
densely ionizing radiation is just as effective per track but less
effective per unit dose.
• The most biologically effective LET is that at which there is a
coincidence between the diameter of the DNA helix and the average
separation of ionizing events.
• Radiations having this optimal LET include neutrons of a few hundred
kiloelectron volts as well as low-energy protons and α-particles.
RBE depends on the following:
• Radiation quality (LET) (The type of radiation and its energy, whether
electromagnetic or particulate, and whether charged or uncharged)
• Radiation dose & Number of dose fractions (The shape of the dose–
response relationship varies for radiations that differ substantially in
their LET).
• Dose rate (The slope of the dose–response curve for sparsely ionizing
radiations, such as x- or γ-rays, varies critically with a changing dose
rate. In contrast, the biologic response to densely ionizing radiations
depends little on the rate at which the radiation is delivered)
• Biologic system or end point(RBE values are high for tissues that
accumulate and repair a great deal of sublethal damage and low for
those that do not)
x-rays, which are sparsely ionizing, have a low LET,
and consequently exhibit a large OER of about 2.5.
Neutrons, which are intermediate in ionizing
density and characteristically show an OER of 1.6.
2.5-MeV α-particles, which are densely ionizing and have a high LET; in
this case, survival estimates, whether in the presence or absence of
oxygen, fall along a common line, and so the OER is unity.
Variation of the oxygen enhancement ratio (OER) and the
relative biologic effectiveness (RBE) as a function of the linear
energy transfer (LET) of the radiation involved.
The rapid increase in RBE and the rapid fall of the OER occur at about the
same LET, 100 keV/μm.
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO
OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO

More Related Content

Similar to OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO

Radiobiology- Basic Guide
Radiobiology- Basic Guide Radiobiology- Basic Guide
Radiobiology- Basic Guide Aaditya Sinha
 
Biological basis of proton and high let beam
Biological basis of proton and high let beamBiological basis of proton and high let beam
Biological basis of proton and high let beamMahran Alnahmi
 
RADIOBIOLOGY: oxygen effect & reoxygenation
RADIOBIOLOGY: oxygen effect & reoxygenationRADIOBIOLOGY: oxygen effect & reoxygenation
RADIOBIOLOGY: oxygen effect & reoxygenationIsha Jaiswal
 
Glimpse of clinical radiobiology course
Glimpse of clinical radiobiology courseGlimpse of clinical radiobiology course
Glimpse of clinical radiobiology courseManoj Gupta
 
Biological effects of radiation- RAVISHWAR NARAYAN
Biological effects of radiation- RAVISHWAR NARAYANBiological effects of radiation- RAVISHWAR NARAYAN
Biological effects of radiation- RAVISHWAR NARAYANRavishwar Narayan
 
Cell survival curve ppt.
Cell survival curve ppt.Cell survival curve ppt.
Cell survival curve ppt.Luri Borah
 
Biological effects of radiation
Biological effects of radiationBiological effects of radiation
Biological effects of radiationDR.URVASHI NIKTE
 
X rays discovered on nov
X rays discovered on novX rays discovered on nov
X rays discovered on novRekha Pathak
 
Biological effects of radiations
Biological effects of radiationsBiological effects of radiations
Biological effects of radiationsMirza Anwar Baig
 
Importance of oxygen in radiotherapy
Importance of oxygen in radiotherapyImportance of oxygen in radiotherapy
Importance of oxygen in radiotherapyNamrata Das
 
Uv-visible spectroscopy
Uv-visible spectroscopyUv-visible spectroscopy
Uv-visible spectroscopyMzgin Mohammed
 
Cell survival curves
Cell survival curvesCell survival curves
Cell survival curvesSavioJames4
 

Similar to OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO (20)

LET, RBE & OER - dr vandana
LET, RBE & OER - dr vandanaLET, RBE & OER - dr vandana
LET, RBE & OER - dr vandana
 
Radiobiology- Basic Guide
Radiobiology- Basic Guide Radiobiology- Basic Guide
Radiobiology- Basic Guide
 
LET RBE OER
LET RBE OERLET RBE OER
LET RBE OER
 
Biological basis of proton and high let beam
Biological basis of proton and high let beamBiological basis of proton and high let beam
Biological basis of proton and high let beam
 
Radiobiology
RadiobiologyRadiobiology
Radiobiology
 
Linear energy transfer and Radiation fractionation
Linear energy transfer and Radiation fractionationLinear energy transfer and Radiation fractionation
Linear energy transfer and Radiation fractionation
 
RADIOBIOLOGY: oxygen effect & reoxygenation
RADIOBIOLOGY: oxygen effect & reoxygenationRADIOBIOLOGY: oxygen effect & reoxygenation
RADIOBIOLOGY: oxygen effect & reoxygenation
 
Radiobiology
RadiobiologyRadiobiology
Radiobiology
 
Glimpse of clinical radiobiology course
Glimpse of clinical radiobiology courseGlimpse of clinical radiobiology course
Glimpse of clinical radiobiology course
 
Biological effects of radiation- RAVISHWAR NARAYAN
Biological effects of radiation- RAVISHWAR NARAYANBiological effects of radiation- RAVISHWAR NARAYAN
Biological effects of radiation- RAVISHWAR NARAYAN
 
Cell survival curve ppt.
Cell survival curve ppt.Cell survival curve ppt.
Cell survival curve ppt.
 
Biological effects of radiation
Biological effects of radiationBiological effects of radiation
Biological effects of radiation
 
X rays discovered on nov
X rays discovered on novX rays discovered on nov
X rays discovered on nov
 
Chap6 oxygen effect and reoxygenation
Chap6 oxygen effect and reoxygenationChap6 oxygen effect and reoxygenation
Chap6 oxygen effect and reoxygenation
 
Biological effects of radiations
Biological effects of radiationsBiological effects of radiations
Biological effects of radiations
 
Importance of oxygen in radiotherapy
Importance of oxygen in radiotherapyImportance of oxygen in radiotherapy
Importance of oxygen in radiotherapy
 
RADIATION
RADIATIONRADIATION
RADIATION
 
Uv-visible spectroscopy
Uv-visible spectroscopyUv-visible spectroscopy
Uv-visible spectroscopy
 
Presentation2
Presentation2Presentation2
Presentation2
 
Cell survival curves
Cell survival curvesCell survival curves
Cell survival curves
 

Recently uploaded

Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpinRaunakKeshri1
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfJayanti Pande
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesFatimaKhan178732
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docxPoojaSen20
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfciinovamais
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 

Recently uploaded (20)

Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpin
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 
Staff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSDStaff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSD
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and Actinides
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docx
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 

OER RADIATION ONCOLOGY ; OXYGEN ENHANCEMENT RATIO

  • 1. OER / RBE / LET Dr ANJALIKRISHNA NP PG RESIDENT RADIOTHERAPY
  • 3. OXYGEN EFFECT • Cells are much more sensitive to radiation in the presence of oxygen • The formation of RO2·, an organic peroxide, represents a non restorable form of the target material; that is, the reaction results in a change in the chemical composition of the material exposed to the radiation. • This reaction cannot take place in the absence of oxygen. • Oxygen fixes ( ie , makes permanent ) the damage produced by free radicals . • In the absence of oxygen , damage produced by the indirect action may be repaired .
  • 4. The oxygen fixation hypothesis. About two-thirds of the damage produced by x-rays is by indirect action mediated by free radicals. The damage produced by free radicals in DNA can be repaired under hypoxia but may be “fixed” (made permanent and irreparable) if molecular oxygen is available .
  • 5. • To produce its effect , molecular oxygen must be present during the radiation exposure or at least during the lifetime of the free radicals generated by the radiation . • Ie , Oxygen effect is time dependent . 1. O2 needs to be present during radiation . or 2. O2 has to be present within milliseconds after radiation . • Radiation - ion pairs - free radicals 0.01 msec. OXYGEN IS NATURAL RADIOSENITIZER .
  • 6. • If molecular oxygen is present, DNA reacts with the free radicals (R·). The DNA radical can be chemically restored to its reduced form through reaction with a sulfhydryl (SH) group. • SULFHYDRIL group is a natural radio protector which exert their effect by scavenging free radicals . • Oxygen and sulfhydryl only acts on indirect action and they do not have any effect on direct action of radiation to DNA .
  • 7. RADIOSENSITIVITY & O2 CONCENTRATION
  • 8. • Very little change upto 20 mmHg. • Sharp fall in sensitivity and reduces to half at around 3 mmHg. • Maximum radio resistance at 1/100 mm of Hg . • Oxygen tension in most of tissue is similar at venous blood O2 tension ,ie 20-40 mmHg .So , MOST OF THE NORMAL TISSUES HAVE GOOD SENSITIVITY TO RADIATION.
  • 9. EFFECT OF O2 on cell survival curve .
  • 10. • So , to get the same surviving fraction , dose of RT to be increased with decreasing oxygen tension . • The ratio of RT to get the same SF in hypoxic cells to oxic cells is known as OXYGEN ENHANCEMENT RATIO (OER). • OER = DH / DO = D hypoxic/D aerobic • Ratio of doses administered under hypoxic to aerated condition needed to achieve the same biological effect is called oxygen enhancement ratio .
  • 11. • For sparsely ionizing radiations, such as x- and γ-rays, the OER at high doses has a value of between 2.5 and 3.5. • For a densely ionizing radiation, such as low-energy α-particles, the survival curve does not have an initial shoulder; which means that all hits results into cell kill and no sub lethal damage to be fixed by oxygen .we can say , α-particle radiation is as effective for hypoxic cells as for oxic cell . • Intermediate value for fast neutrons , the OER for neutrons is about 1.6. For radiations of intermediate ionizing density, such as neutrons, the survival curves have a much reduced shoulder
  • 12. Survival curves for mammalian cells exposed to x-rays in the presence and absence of oxygen are illustrated here;
  • 13. • High dose region ; predominant process of cell kill is by accumulation of sublethal damage ( cell killing by multiple hit event –MHE ) which can be repaired ,so oxygen fix it and repair slows down . • Low dose region ; cell killing is predominantly by single hit event –SHE ,no sublethal damage to be fixed up by oxygen ; so , in low dose region OER = 2 ( x ray or gamma ray )
  • 14. • Cells are much more sensitive to x-rays in the presence of molecular oxygen than in its absence (i.e., under hypoxia). • The ratio of doses under hypoxic to aerated conditions necessary to produce the same level of cell killing is called the oxygen enhancement ratio (OER). • It has a value close to 3.5 at high doses (A) • But may have a lower value of about 2.5 at x-ray doses less than about 2 to 3 Gy (B).
  • 15. • OER varies slightly during cell cycle . • Cells in G1 phase have a lower OER than those in S, and because G1 cells are more radiosensitive, they dominate the low-dose region of the survival curve. • S PHASE > G1 PHASE > G2/M PHASE . • OER OF S PHASE = 2.8 - 2.9 • OER OF G2/M PHASE = 2.3 -2.4
  • 16. CLINICAL IMPORTANCE • Various experimental solid tumors in animals have shown to have hypoxic contents between 10 to 40 %, which limits the radio curability • However , it should be remembered that even a minute proportion of hypoxic cells will limit the radiocurability if treated with large single fraction . • There are abundant evidences to support the existence of hypoxic cells in human tumour .
  • 17. TUMOR HYPOXIA & DFS IN CA CERVIX
  • 18. HYPOXIA & local tumor control in HEAD & NECK CANCER
  • 19. LINEAR ENERGY TRANSFER • Linear energy transfer (LET) is the energy transferred per unit length of the track. • The special unit usually used for this quantity is kiloelectron volt per micrometer (keV/μm) of unit density material. • The LET (L) of charged particles in medium is the quotient of dE/dl. • dE is the average energy locally imparted to the medium by a charged particle of specified energy in traversing a distance of dl. • L=dE/dl
  • 20.
  • 21. Typical Linear Energy Transfer Values
  • 22. • Linear energy transfer (LET) is the average energy deposited per unit length of track. • The track average is calculated by dividing the track into equal lengths and averaging the energy deposited in each length. • The energy average is calculated by dividing the track into equal energy intervals and averaging the lengths of the track that contain this amount of energy. • The method of averaging makes little difference for x-rays or for monoenergetic charged particles, but the track average and energy average are different for neutrons. • In the case of either x-rays or monoenergetic charged particles, the two methods of averaging yield similar results. • In the case of 14-MeV neutrons, by contrast, the track average LET is about 12 keV/μm and the energy average LET is about 100 keV/μm. • The biologic properties of neutrons tend to correlate best with the energy average.
  • 23. RELATIVE BIOLOGIC EFFECTIVENESS (RBE) • The amount or quantity of radiation is expressed in terms of the absorbed dose, a physical quantity with the unit of gray (Gy). • Absorbed dose is a measure of the energy absorbed per unit mass of tissue. • Equal doses of different types of radiation do not produce equal biologic effects. • For example, 1 Gy of neutrons produces a greater biologic effect than 1 Gy of x-rays. • The key to the difference lies in the pattern of energy deposition at the microscopic level.
  • 25. • why radiation with an LET of about 100 keV/μm is optimal in terms of producing a biologic effect? • LET of about 100 keV/μm is optimal in terms of producing a biologic effect . • At this density of ionization , the average separation in ionizing events is equal to the diameter of DNA double helix (i.e., about 20 Å or 2 nm) which causes significant DOUBLE STRAND BREAK . • DSB are the basis of most biological effects . • The probability of causing DSBs is low in sparsely ionizing radiation . • The LET at which the RBE reaches a peak is much the same (about 100 keV/ μm) for a wide range of mammalian cells, from mouse to human, and is the same for mutation as an end point as for cell killing.
  • 26.
  • 27. • Variation of relative biologic effectiveness (RBE) with linear energy transfer (LET) for survival of mammalian cells of human origin. The RBE rises to a maximum at an LET of about 100 keV/μm and subsequently falls for higher values of LET. Curves 1, 2, and 3 refer to cell survival levels of 0.8, 0.1, and 0.01, respectively, illustrating that the absolute value of the RBE is not unique but depends on the level of biologic damage and, therefore, on the dose level.
  • 28. • In the case of x-rays, which are more sparsely ionizing, the probability of a single track causing a DSB is low, and in general, more than one track is required. As a consequence, x-rays have a low biologic effectiveness. • At the other extreme, much more densely ionizing radiations (e.g., with an LET of 200 keV/μm) readily produce DSBs. • But energy is “wasted” • Because, the ionizing events are too close together. RBE is the ratio of doses producing equal biologic effect, this more densely ionizing radiation has a lower RBE than the optimal LET radiation. The more densely ionizing radiation is just as effective per track but less effective per unit dose.
  • 29. • The most biologically effective LET is that at which there is a coincidence between the diameter of the DNA helix and the average separation of ionizing events. • Radiations having this optimal LET include neutrons of a few hundred kiloelectron volts as well as low-energy protons and α-particles.
  • 30. RBE depends on the following: • Radiation quality (LET) (The type of radiation and its energy, whether electromagnetic or particulate, and whether charged or uncharged) • Radiation dose & Number of dose fractions (The shape of the dose– response relationship varies for radiations that differ substantially in their LET). • Dose rate (The slope of the dose–response curve for sparsely ionizing radiations, such as x- or γ-rays, varies critically with a changing dose rate. In contrast, the biologic response to densely ionizing radiations depends little on the rate at which the radiation is delivered) • Biologic system or end point(RBE values are high for tissues that accumulate and repair a great deal of sublethal damage and low for those that do not)
  • 31. x-rays, which are sparsely ionizing, have a low LET, and consequently exhibit a large OER of about 2.5.
  • 32. Neutrons, which are intermediate in ionizing density and characteristically show an OER of 1.6.
  • 33. 2.5-MeV α-particles, which are densely ionizing and have a high LET; in this case, survival estimates, whether in the presence or absence of oxygen, fall along a common line, and so the OER is unity.
  • 34. Variation of the oxygen enhancement ratio (OER) and the relative biologic effectiveness (RBE) as a function of the linear energy transfer (LET) of the radiation involved. The rapid increase in RBE and the rapid fall of the OER occur at about the same LET, 100 keV/μm.